Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Leases (2019 - 2025)

Sanofi's Current Leases history spans 7 years, with the latest figure at $316.6 million for Q4 2025.

  • On a quarterly basis, Current Leases rose 13.52% to $316.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $316.6 million, a 13.52% increase, with the full-year FY2025 number at $316.6 million, up 13.52% from a year prior.
  • Current Leases hit $316.6 million in Q4 2025 for Sanofi, up from $285.3 million in the prior quarter.
  • Over the last five years, Current Leases for SNY hit a ceiling of $316.6 million in Q4 2025 and a floor of $246.5 million in Q2 2022.
  • Historically, Current Leases has averaged $288.7 million across 5 years, with a median of $290.6 million in 2023.
  • Biggest five-year swings in Current Leases: dropped 17.13% in 2022 and later increased 13.52% in 2025.
  • Tracing SNY's Current Leases over 5 years: stood at $307.7 million in 2021, then dropped by 8.16% to $282.6 million in 2022, then rose by 4.7% to $295.9 million in 2023, then decreased by 5.74% to $278.9 million in 2024, then grew by 13.52% to $316.6 million in 2025.
  • Business Quant data shows Current Leases for SNY at $316.6 million in Q4 2025, $285.3 million in Q2 2025, and $278.9 million in Q4 2024.